The animal study showed that epigallocatechin-3-gallate (10–50 mg/kg) inhibited the expression of URAT1 and promoted uric acid excretion in hyperuricemia mice induced by potassium oxonate [53]. Here, SLC22A12 is linked to hyperuricemia.